Ending an epidemic: Prioritizing people who inject drugs in HCV elimination efforts
July 2018

Fuelled by political will, resources for cost-effective, evidencebased prevention programmes and momentum for revolutionary advances in hepatitis C virus (HCV) treatment is building towards halting a deadly global epidemic. Worldwide, an estimated 71 million people are living with hepatitis C, a blood- borne virus that infects liver cells.

Read more